cl 387785 has been researched along with Stomach Neoplasms in 1 studies
CL 387785: structure in first source
N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}but-2-ynamide : A member of the class of quinazolines that is 4,6-diaminoquinazoine in which the one of the hydrogens attached to the amino group at position 4 has been replaced by a m-bromophenyl group while one of the hydrogens attached to the amino group at position 6 has been replaced by a but-2-ynoyl group.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomioka, H | 1 |
| Mukohara, T | 1 |
| Kataoka, Y | 1 |
| Ekyalongo, RC | 1 |
| Funakoshi, Y | 1 |
| Imai, Y | 1 |
| Kiyota, N | 1 |
| Fujiwara, Y | 1 |
| Minami, H | 1 |
1 other study available for cl 387785 and Stomach Neoplasms
| Article | Year |
|---|---|
Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification.
Topics: Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cel | 2012 |